Plain-English translation of NCT06604494 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether doctors can predict dangerous throat complications (called fistulas) after larynx removal surgery by measuring certain immune markers in surgical drainage fluid on the second day after surgery. The goal is to catch problems early so patients can get the right care faster and recover better. By identifying which patients are at high risk, doctors can adjust their post-surgery care plan right away.
After larynx removal surgery, some patients develop serious throat complications that delay healing and require extra treatment. This study exists to find a simple, early warning sign—using fluid that's already being collected from surgical drains—so doctors can spot trouble before it becomes severe and adjust care immediately.
You likely qualify if…
You likely don't qualify if…
If you enroll, your surgical team will place a standard drainage tube during your larynx removal surgery. On the second day after surgery, doctors will collect the fluid that has accumulated in the drain and test it for immune markers. Based on these results, your post-surgery care plan may be adjusted—for example, when you can start eating again. You'll receive care from specialized hospitals across multiple French cancer centers, and your progress will be monitored according to the study protocol.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France